A. N. Mayeno

发表

Cytochromes P450: a structure-based summary of biotransformations using representative substrates.

C. Brown, B. Reisfeld, A. N. Mayeno, 2008, Drug metabolism reviews.

Computational Toxicology

B. Reisfeld, A. N. Mayeno, John M. Walker, 2013, Methods in Molecular Biology.

Granule‐associated flavin adenine dinucleotide (FAD) is responsible for eosinophil autofluorescence

A. N. Mayeno, G. Gleich, K. Hamann, 1992, Journal of leukocyte biology.

Biochemical reaction network modeling: predicting metabolism of organic chemical mixtures.

Raymond S H Yang, Brad Reisfeld, Arthur N Mayeno, 2005, Environmental science & technology.

The Application of Physiologically Based Pharmacokinetics, Bayesian Population PBPK Modeling, and Biochemical Reaction Network Modeling to Chemical Mixture Toxicology

Raymond S. H. Yang, B. Reisfeld, A. N. Mayeno, 2010 .

On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome.

L. Benson, A. Tomlinson, Stephen Naylor, 1997, Toxicology letters.

Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale.

A. N. Mayeno, G. Gleich, 1994, Trends in biotechnology.

1,1' ‐Ethylidenebis‐ [tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia‐myalgia syndrome

A. Engel, A. N. Mayeno, S. Nakano, 1994, Neurology.

Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination.

H. Kita, A. N. Mayeno, J. Abrams, 1995, The Journal of allergy and clinical immunology.

Eosinophils preferentially use bromide to generate halogenating agents.

A. N. Mayeno, C. Foote, A. Curran, 1989, The Journal of biological chemistry.

Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.

A. N. Mayeno, D. Loegering, M. Ames, 1990, Science.

Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil‐active cytokines

H. Kita, A. N. Mayeno, D. Broide, 1996, Clinical and experimental immunology.

The eosinophilia-myalgia syndrome: lessons from Germany.

A. N. Mayeno, G. Gleich, 1994, Mayo Clinic proceedings.

The eosinophilia-myalgia syndrome and tryptophan.

M. Osterholm, E. Belongia, A. N. Mayeno, 1992, Annual review of nutrition.

A novel, sensitive method for determining benzo[a]pyrene-diones using high-performance liquid chromatography with post-column zinc reduction.

Raymond S. H. Yang, A. N. Mayeno, K. Reardon, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.

A. N. Mayeno, J. Varga, J. Zangrilli, 1995, Biochemistry and molecular biology international.

3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?

E. Belongia, A. N. Mayeno, G. Gleich, 1992, Mayo Clinic proceedings.

Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates

Arthur N. Mayeno, Brad Reisfeld, C. Brown, 2008 .

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

M. Osterholm, E. Belongia, A. N. Mayeno, 1990, The New England journal of medicine.

Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data

Arthur N. Mayeno, Brad Reisfeld, Raymond S. H. Yang, 2008, Environmental health perspectives.

EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog.

A. N. Mayeno, A. Pastuszyn, A. Bankhurst, 1996, Autoimmunity.

Computational Toxicology

Arthur N. Mayeno, Brad Reisfeld, John M. Walker, 2013, Methods in Molecular Biology.

Tools and techniques.

Brad Reisfeld, Arthur N Mayeno, B. Reisfeld, 2012, Methods in molecular biology.

Quantum chemical prediction of redox reactivity and degradation pathways for aqueous phase contaminants: an example with HMPA.

T. Sale, A. N. Mayeno, T. Borch, 2010, Environmental science & technology.

Membrane preconcentration‐capillary electrophoresis‐mass spectrometry (mPC‐CE‐MS) analysis of 3‐phenylamino‐1,2‐propanediol (PAP) metabolites

L. Benson, A. Tomlinson, A. N. Mayeno, 1996 .

Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.

L. Benson, A. N. Mayeno, S. Naylor, 1995, Chemical research in toxicology.

A Physiologically Based Pharmacokinetic Model for Capreomycin

B Reisfeld, C P Metzler, M A Lyons, 2011, Antimicrobial Agents and Chemotherapy.

Prediction of contaminant persistence in aqueous phase: a quantum chemical approach.

T. Sale, A. N. Mayeno, T. Borch, 2011, Environmental science & technology.

Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome.

A N Mayeno, A. N. Mayeno, P. Latham, 1994, Toxicology and applied pharmacology.

Rapid estimation of activation enthalpies for cytochrome‐P450‐mediated hydroxylations

Arthur N. Mayeno, Jonathan L. Robinson, Brad Reisfeld, 2011, J. Comput. Chem..

Predicting Activation Enthalpies of Cytochrome-P450-Mediated Hydrogen Abstractions. 2. Comparison of Semiempirical PM3, SAM1, and AM1 with a Density Functional Theory Method

Arthur N. Mayeno, Jonathan L. Robinson, Brad Reisfeld, 2009, J. Chem. Inf. Model..

The Mechanism of C-H Bond Oxidation by Aqueous Permanganate.

T. Sale, A. Rappé, A. N. Mayeno, 2018, Environmental science & technology.